التفاصيل البيبلوغرافية
| العنوان: |
Enhanced Creutzfeldt‐Jakob disease surveillance in the older population: Assessment of a protocol for screening brain tissue donations for prion disease. |
| المؤلفون: |
Peden, Alexander H.1 (AUTHOR) a.peden@ed.ac.uk, Libori, Adriana1 (AUTHOR), Ritchie, Diane L.1 (AUTHOR), Yull, Helen1 (AUTHOR), Smith, Colin1,2 (AUTHOR), Kanguru, Lovney1 (AUTHOR), Molesworth, Anna1 (AUTHOR), Knight, Richard1 (AUTHOR), Barria, Marcelo A.1 (AUTHOR) marcelo.barria@ed.ac.uk |
| المصدر: |
Brain Pathology. Mar2024, Vol. 34 Issue 2, p1-12. 12p. |
| مصطلحات موضوعية: |
*PRION diseases, *CREUTZFELDT-Jakob disease, *ORGAN donation, *NEUROANATOMY, *BOVINE spongiform encephalopathy, *BRAIN banks |
| مصطلحات جغرافية: |
UNITED Kingdom |
| مستخلص: |
Human prion diseases, including Creutzfeldt‐Jakob disease (CJD), occur in sporadic, genetic, and acquired forms. Variant Creutzfeldt‐Jakob disease (vCJD) first reported in 1996 in the United Kingdom (UK), resulted from contamination of food with bovine spongiform encephalopathy. There is a concern that UK national surveillance mechanisms might miss some CJD cases (including vCJD), particularly in the older population where other neurodegenerative disorders are more prevalent. We developed a highly sensitive protocol for analysing autopsy brain tissue for the misfolded prion protein (PrPSc) associated with prion disease, which could be used to screen for prion disease in the elderly. Brain tissue samples from 331 donors to the Edinburgh Brain and Tissue Bank (EBTB), from 2005 to 2022, were analysed, using immunohistochemical analysis on fixed tissue, and five biochemical tests on frozen specimens from six brain regions, based on different principles for detecting PrPSc. An algorithm was established for classifying the biochemical results. To test the effectiveness of the protocol, several neuropathologically confirmed prion disease controls, including vCJD, were included and blinded in the study cohort. On unblinding, all the positive control cases had been correctly identified. No other cases tested positive; our analysis uncovered no overlooked prion disease cases. Our algorithm for classifying cases was effective for handling anomalous biochemical results. An overall analysis suggested that a reduced biochemical protocol employing only three of the five tests on only two brain tissue regions gave sufficient sensitivity and specificity. We conclude that this protocol may be useful as a UK‐wide screening programme for human prion disease in selected brains from autopsies in the elderly. Further improvements to the protocol were suggested by enhancements of the in vitro conversion assays made during the course of this study. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder